AcuraBio

AcuraBio, formerly Luina Bio, is one of Australia's most experienced biologics CDMOs, based in Brisbane and recently acquired by biotech investor Dr. Glenn Haifer and US private equity firm Ampersand Capital Partners. The company offers process development and GMP manufacturing of recombinant proteins, vaccines and live biotherapeutics for human and veterinary use, producing material for pre-clinical studies and Phase 1-3 clinical trial GMP batches, backed by more than 20 years of contract manufacturing experience. AcuraBio holds a TGA license for manufacturing human therapeutic APIs from biological and synthetic sources, an APVMA license for sterile immunobiological products, and an OGTR license for products from genetically modified organisms.